Excellence in Cosmetic Research since 1993


Learn about our compatibility studies and regularize your product with ANVISA.

Assessment conducted under controlled conditions of potentially irritative and allergenic products through Patch Tests.

  • RIPT
  • Primary Irritation (IP)
  • Cumulative Irritation
  • 21 DCI (Irritation)
  • Sensitization
  • Photoallergy
  • Phototoxicity


The comedogenicity test evaluates the action of cosmetic products ingredients in the emergence of black spots and comedones on the skin, mainly on the face.

Comedogenicity in Patch Test

Comedogenic Potential Assessment - product capacity to cause black heads and pimples - through laboratory and clinical evaluations.

In-Use Acnegenicity

Evaluation of the acnegenic Potential under real use conditions and through clinical assessments.


  • Non-Acnegenic
  • Non-Comedogenic
  • Dermatologically Tested

Eye Irritation

Evaluation of the eye irritation potential of products such as shampoos, conditioners and high softness soaps (Ex: Products for children) carried out by ophthalmologists after eye instillation.


  • No Tears
  • Tear-Free
  • Does Not Irritate the Eyes

In-Use Acceptance

In-use "Acceptance Assessment" to prove the non-occurrence of adverse reactions, under real use conditions and foreseeable and reasonably foreseeable situations. The studies can be conducted in special population: Pediatric, Sensitive skin, Atopic Skin, Photo-aged Skin, Acneic Skin, among others. They also can be conducted by different clinical expertises: Dermatologist, Pediatrician, Ophthalmologist, Gynecologist, Urologist, Dentist.

  • Dermatologically Tested
  • Clinically Tested
  • For Sensitive Skin
  • Assessed By Pediatricians
  • Ophthalmologically Tested
  • Assessed By an Urologist
  • Assessed By a Gynecologist
  • Assessed By a Dentist